Liberum Capital Reaffirms “Buy” Rating for Reckitt Benckiser Group (LON:RB)
Liberum Capital reiterated their buy rating on shares of Reckitt Benckiser Group (LON:RB) in a research report report published on Thursday morning, ThisIsMoney.Co.Uk reports.
A number of other research firms have also recently commented on RB. Shore Capital restated a house stock rating on shares of in a research report on Wednesday, June 12th. Goldman Sachs Group set a GBX 6,870 ($89.77) target price on Reckitt Benckiser Group and gave the company a neutral rating in a research report on Tuesday, June 25th. Royal Bank of Canada cut 3M from an outperform rating to a sector perform rating and dropped their target price for the company from $207.00 to $176.00 in a research report on Monday, July 8th. Credit Suisse Group restated a hold rating on shares of FactSet Research Systems in a research report on Monday, July 8th. Finally, Morgan Stanley restated an overweight rating on shares of in a research report on Thursday, June 20th. Three investment analysts have rated the stock with a sell rating, four have assigned a hold rating and twelve have given a buy rating to the stock. The company currently has a consensus rating of Hold and a consensus price target of GBX 7,211.11 ($94.23).
LON:RB opened at GBX 6,595 ($86.18) on Thursday. Reckitt Benckiser Group has a 52 week low of GBX 5,559 ($72.64) and a 52 week high of GBX 7,174 ($93.74). The company has a debt-to-equity ratio of 80.49, a current ratio of 0.65 and a quick ratio of 0.47. The firm has a market cap of $46.76 billion and a PE ratio of 21.64. The company’s 50-day simple moving average is GBX 6,384.22.
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Featured Story: How are the companies in the S&P 500 selected?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.